BIIB021 Free base
To Order Contact us: [email protected]
BIIB021 |
|||
| A4058-50 | ApexBio | 50 mg | EUR 168 |
|
Description: Metabolism|HSP#Proteases|HSP |
|||
BIIB021 |
|||
| 200505 | MedKoo Biosciences | 10.0mg | EUR 150 |
BIIB021 |
|||
| abx188616-96tests | Abbexa | 96 tests | EUR 118.75 |
BIIB021 |
|||
| HY-10212 | MedChemExpress | 50mg | EUR 250 |
|
Description: BIIB021 (CNF2024) is an orally active, fully synthetic inhibitor of HSP90 with a Ki and an EC50 of 1.7 nM and 38 nM, respectively[1]. |
|||
BIIB021 |
|||
| MBS384528-100mg | MyBiosource | 100mg | EUR 430 |
BIIB021 |
|||
| MBS384528-10mg | MyBiosource | 10mg | EUR 170 |
BIIB021 |
|||
| MBS384528-1mLinDMSO | MyBiosource | 1mL(inDMSO) | EUR 145 |
BIIB021 |
|||
| MBS384528-50mg | MyBiosource | 50mg | EUR 300 |
BIIB021 |
|||
| MBS384528-5mg | MyBiosource | 5mg | EUR 145 |
BIIB021 |
|||
| MBS3606160-100mg | MyBiosource | 100mg | EUR 435 |
BIIB021 |
|||
| MBS3606160-10mg | MyBiosource | 10mg | EUR 225 |
BIIB021 |
|||
| MBS3606160-25mg | MyBiosource | 25mg | EUR 260 |
BIIB021 |
|||
| MBS3606160-50mg | MyBiosource | 50mg | EUR 340 |
BIIB021 |
|||
| MBS3606160-5mg | MyBiosource | 5mg | EUR 210 |
BIIB021 |
|||
| T2286-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: BIIB021 |
|||
BIIB021 |
|||
| T2286-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: BIIB021 |
|||
BIIB021 |
|||
| T2286-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: BIIB021 |
|||
BIIB021 |
|||
| T2286-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: BIIB021 |
|||
BIIB021 |
|||
| T2286-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: BIIB021 |
|||
BIIB068 |
|||
| 462609 | MedKoo Biosciences | 50.0mg | EUR 950 |
Biib-021 |
|||
| abx188616-1g | Abbexa | 1 g | EUR 910.8 |
BIIB068 |
|||
| HY-131342 | MedChemExpress | 10 mg | EUR 1130.97 |
|
Description: BIIB068 is a potent, selective, reversible and orally active BTK inhibitor with an IC50 of 1 nM and a Kd of 0.3 nM. BIIB068 shows more >400-fold selective for BTK than other kinases. BIIB068 has the potential for autoimmune diseases research[1]. |
|||
BIIB091 |
|||
| HY-139984 | MedChemExpress | 10 mg | EUR 6764.18 |
|
Description: BIIB091 is a potent, selective, orally active and reversible BTK inhibitor, with an IC50 of <0.5 nM. BIIB091 binds the BTK protein to sequester TYR-551 into an inactive conformation with excellent affinity. BIIB091 can be used for the research of multiple sclerosis[1]. |
|||
BIIB068 |
|||
| MBS5765268-10mg | MyBiosource | 10mg | EUR 310 |
BIIB068 |
|||
| MBS5765268-1mg | MyBiosource | 1mg | EUR 170 |
BIIB068 |
|||
| MBS5765268-25mg | MyBiosource | 25mg | EUR 515 |
BIIB068 |
|||
| MBS5765268-50mg | MyBiosource | 50mg | EUR 835 |
BIIB068 |
|||
| MBS5765268-5mg | MyBiosource | 5mg | EUR 240 |
BIIB091 |
|||
| MBS5800174-10mg | MyBiosource | 10mg | EUR 2020 |
BIIB091 |
|||
| MBS5800174-5mg | MyBiosource | 5(mg | EUR 1280 |
BIIB091 |
|||
| MBS5800174-5x10mg | MyBiosource | 5x10(mg | EUR 8930 |
BIIB-513 |
|||
| MBS5776535-5mg | MyBiosource | 5(mg | EUR 915 |
BIIB-513 |
|||
| MBS5776535-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
BIIB-021 |
|||
| MBS578035-100mg | MyBiosource | 100mg | EUR 305 |
BIIB-021 |
|||
| MBS578035-10mg | MyBiosource | 10mg | EUR 155 |
BIIB-021 |
|||
| MBS578035-25mg | MyBiosource | 25mg | EUR 185 |
BIIB-021 |
|||
| MBS578035-50mg | MyBiosource | 50mg | EUR 240 |
BIIB-021 |
|||
| MBS578035-5mg | MyBiosource | 5mg | EUR 140 |
BIIB-057 |
|||
| MBS5773557-5mg | MyBiosource | 5mg | EUR 915 |
BIIB-057 |
|||
| MBS5773557-5x5mg | MyBiosource | 5x5mg | EUR 3970 |
BIIB-513 |
|||
| T26808-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: BIIB-513 |
|||
BIIB-513 |
|||
| T26808-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: BIIB-513 |
|||
BIIB-513 |
|||
| T26808-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: BIIB-513 |
|||
BIIB-513 |
|||
| T26808-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: BIIB-513 |
|||
BIIB-513 |
|||
| T26808-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: BIIB-513 |
|||
BIIB-057 |
|||
| T23790-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: BIIB-057 |
|||
BIIB-057 |
|||
| T23790-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: BIIB-057 |
|||
BIIB-057 |
|||
| T23790-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: BIIB-057 |
|||
BIIB-057 |
|||
| T23790-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: BIIB-057 |
|||
BIIB-057 |
|||
| T23790-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: BIIB-057 |
|||
BIIB091 |
|||
| T39761-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: BIIB091 |
|||
BIIB091 |
|||
| T39761-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: BIIB091 |
|||
BIIB091 |
|||
| T39761-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: BIIB091 |
|||
BIIB091 |
|||
| T39761-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: BIIB091 |
|||
BIIB091 |
|||
| T39761-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: BIIB091 |
|||
BIIB068 |
|||
| T9192-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: BIIB068 |
|||
BIIB068 |
|||
| T9192-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: BIIB068 |
|||
BIIB068 |
|||
| T9192-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: BIIB068 |
|||
BIIB068 |
|||
| T9192-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: BIIB068 |
|||
BIIB068 |
|||
| T9192-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: BIIB068 |
|||
(Rac)-BIIB042 |
|||
| HY-103537 | MedChemExpress | Get quote | Ask for price |
|
Description: (Rac)-BIIB042 (Compound 10) is an modulator of γ-Secretase. (Rac)-BIIB042 reduces Amyloid-β 42 level with an EC50 value of 0.39 µM. (Rac)-BIIB042 can be used for the study of Alzheimer's disease[1]. |
|||
MLN2480 (BIIB-024) |
|||
| MBS385162-10mg | MyBiosource | 10mg | EUR 345 |
MLN2480 (BIIB-024) |
|||
| MBS385162-25mg | MyBiosource | 25mg | EUR 615 |
MLN2480 (BIIB-024) |
|||
| MBS385162-50mg | MyBiosource | 50mg | EUR 985 |
MLN2480 (BIIB-024) |
|||
| MBS385162-5mg | MyBiosource | 5mg | EUR 240 |
MLN2480 (BIIB-024) |
|||
| MBS385162-5x50mg | MyBiosource | 5x50mg | EUR 4420 |
Vipadenant (BIIB-014) |
|||
| MBS131433-100mg | MyBiosource | 100mg | EUR 1495 |
Vipadenant (BIIB-014) |
|||
| MBS3840123-10mg | MyBiosource | 10mg | EUR 240 |
Vipadenant (BIIB-014) |
|||
| MBS3840123-50mg | MyBiosource | 50mg | EUR 575 |
Vipadenant (BIIB-014) |
|||
| MBS3840123-5mg | MyBiosource | 5mg | EUR 175 |
Vipadenant (BIIB-014) |
|||
| MBS3840123-5x50mg | MyBiosource | 5x50mg | EUR 2570 |
P505-15 (PRT062607, BIIB057) |
|||
| MBS385876-10mg | MyBiosource | 10mg | EUR 270 |
P505-15 (PRT062607, BIIB057) |
|||
| MBS385876-1mLinDMSO | MyBiosource | 1mL(inDMSO) | EUR 230 |
P505-15 (PRT062607, BIIB057) |
|||
| MBS385876-25mg | MyBiosource | 25mg | EUR 465 |
P505-15 (PRT062607, BIIB057) |
|||
| MBS385876-50mg | MyBiosource | 50mg | EUR 750 |
P505-15 (PRT062607, BIIB057) |
|||
| MBS385876-5mg | MyBiosource | 5mg | EUR 190 |
PRT062607 (P505-15, BIIB057) HCl |
|||
| MBS577157-10mg | MyBiosource | 10mg | EUR 270 |
PRT062607 (P505-15, BIIB057) HCl |
|||
| MBS577157-1mg | MyBiosource | 1mg | EUR 155 |
PRT062607 (P505-15, BIIB057) HCl |
|||
| MBS577157-25mg | MyBiosource | 25mg | EUR 400 |
PRT062607 (P505-15, BIIB057) HCl |
|||
| MBS577157-2mg | MyBiosource | 2mg | EUR 180 |
PRT062607 (P505-15, BIIB057) HCl |
|||
| MBS577157-5mg | MyBiosource | 5mg | EUR 215 |
Anti-CLEC4C Reference Antibody (BIIB059) |
|||
| E24CHA742 | EnoGene | 100 μg | EUR 225 |
|
Description: Available in various conjugation types. |
|||
BIIB 021 |
|||
| 2291-25 | Biovision | each | EUR 483.6 |
BIIB 021 |
|||
| 2291-5 | Biovision | each | EUR 170.4 |
BIIB 021 |
|||
| B384500 | Toronto Research Chemicals | 100mg | EUR 800 |
|
Description: 848695-25-0 |
|||
BIIB 021 |
|||
| MBS132217-100mg | MyBiosource | 100mg | EUR 1065 |
BIIB 021 |
|||
| MBS132217-500mg | MyBiosource | 500mg | EUR 2775 |
BIIB 021 |
|||
| MBS6104269-50mg | MyBiosource | 50(mg | EUR 610 |
BIIB 021 |
|||
| MBS6104269-5x50mg | MyBiosource | 5x50mg | EUR 2600 |
BIIB 021 |
|||
| TRC-B384500-100MG | Toronto Research Chemicals | 100 mg | Ask for price |
I-37 free base (2359690-13-2(free base)) |
|||
| MBS5759495-10mg | MyBiosource | 10mg | EUR 470 |
I-37 free base (2359690-13-2(free base)) |
|||
| MBS5759495-1mg | MyBiosource | 1mg | EUR 210 |
I-37 free base (2359690-13-2(free base)) |
|||
| MBS5759495-25mg | MyBiosource | 25mg | EUR 780 |
